The QualityStocks Daily Wednesday, December 20th, 2023

Today's Top 3 Investment Newsletters

FreeRealTime(POL) $7.6100 +617.92%

FreeRealTime(EBON) $12.4800 +48.06%

QualityStocks(LQDA) $10.7000 +35.70%

The QualityStocks Daily Stock List

Liquidia (LQDA)

MarketClub Analysis, QualityStocks, MarketBeat, StockMarketWatch, TradersPro, BUYINS.NET, Zacks, Trades Of The Day, StreetInsider, Stock Market Watch and Daily Trade Alert reported earlier on Liquidia (LQDA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Liquidia Corp. (NASDAQ: LQDA) (FRA: LT4) is a late-stage clinical biopharm company which develops and commercializes products using its proprietary PRINT technology. The firm was founded in 2004 and has its headquarters in North Carolina, USA. The company prides itself in bringing novel therapeutics to the patients who need them most, and to the healthcare providers who are committed to taking care of those patients.

At the moment, Liquidia is currently focused on improving the precision and outcomes of pulmonary arterial hypertension (PAH) treatment. The company does this largely through its subsidiaries which include Liquidia Technologies Inc. as well as RareGen, LLC.

The firm is currently engaged in taking two drug candidates through the development process. The first is LIQ861, which is an inhaled dry powder made from treprostinil. This formulation is intended to improve the rate at which the drug is delivered deep into the lungs in addition to making it possible for higher doses of this drug to get into the furthest sections of a patient’s lungs. By making these tweaks to the way patients are treated, Liquidia hopes to help the nearly 30,000 patients in the U.S. alone who suffer from the potentially fatal PAH (pulmonary arterial hypertension) disease. This candidate has completed phase 3 clinical trials.

The second candidate is LIQ865. It is designed to deliver the non-opioid anesthetic bupivacaine for the purposes of treating localized post-surgical procedure pain. A single administration (by continuous infusion with the help of a pump or intravenous infusion by use of a catheter) of this drug candidate can manage this type of pain for 3-5 days, thereby eliminating the need for patients to get daily doses of bupivacaine. So far, two phase 1 clinical studies have been completed in addition to toxicological studies as the candidate is prepared for phase 2 trials.

When these candidates complete the clinical phase of their development successfully, the company will be in position to deliver greater shareholder value through serving PAH patients better.

Liquidia (LQDA), closed Wednesday's trading session at $10.7, up 35.7007%, on 15,647,397 volume with 00 trades. The average volume for the last 3 months is 141,033 and the stock's 52-week low/high is $5.67 /$11.35 .

Rare Element Resources (REEMF)

MarketBeat, QualityStocks, TradersPro and InvestorIntel reported earlier on Rare Element Resources (REEMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rare Element Resources Ltd. (OTCQB: REEMF) is a strategic materials firm engaged in exploring for mineral properties, with a focus on rare earth products for technology, energy and defense applications.

The firm has its headquarters in Littleton, Colorado and was incorporated in 1999, on June 3rd by Mark Thomas Brown. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers around the globe, with a focus on those in the United States.

The company operates through the exploration of mineral properties segment. It is focused on delivering strategic materials to technology industries by advancing plans to develop the Bear Lodge Property, located in northeast Wyoming. This property is located 7 air miles (11km) or 12 road miles (19km) northwest of the town of Sundance, Wyoming. The property contains 2 projects; the Bear Lodge Critical Rare Earth (REE) Project, which is located near the town of Sundance in northeast Wyoming; and the Sundance Gold Project. The Bear Lodge REE Project comprises of the Bull Hill mineral district, inclusive of the Bull Hill and Whitetail Ridge deposits and the exploration targets of East Taylor and Carbon. The identified REE deposits and occurrences within the Bear Lodge Property alkaline complex are contained within the company’s block of unpatented lode mining claims.

The firm remains focused on advancing exploration efforts at its properties and advancing its rare earth demonstration plant plans, in a bid to scale-up production while still creating value for its shareholders.

Rare Element Resources (REEMF), closed Wednesday's trading session at $0.172, up -0.921659%, on 165,243 volume with 00 trades. The average volume for the last 3 months is 35,083 and the stock's 52-week low/high is $0.1605 /$0.989 .

Sitka Gold (SITKF)

We reported earlier on Sitka Gold (SITKF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sitka Gold Corp (OTCQB: SITKF) (CNSX: SIG) (FRA: 1RF) is a mineral exploration firm focused on exploring for minerals at resource properties in the U.S. and Canada.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2015, on January 13th. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

The company explores for gold, zinc, silver, and copper deposits. It owns interests in the OGI property, which comprises of 99 quartz mining claims located in Dawson City, Yukon; the Coppermine River project, which covers an area of about 50,000 hectares and is located in Nunavut; the RC Gold property, which comprises of 1,891 claims that cover an area of approximately 37,600 hectares situated in Yukon; and the Alpha Gold property, which includes 293 claims that covers an area of approximately 4780 acres situated in Eureka County, Nevada. The company also holds an option to acquire a 100% interest in the Burro Creek property, which covers an area of about 750 hectares. This property includes 4 patented mineral claims and 35 surrounding lode mineral claims located in the Mohave County, Arizona. It also holds an option to acquire interest in the Barney Ridge property situated to the east of Dawson City, Yukon. In addition to this, it holds a 100% interest in the Mahtin property, which comprises 1,447 quartz mining claims that cover an area of 30,242 hectares located in Yukon territory; and the Clear Creek Gold property, located to the east of Dawson City, Yukon.

The firm, which recently drilled over 1.34 million ounces of gold in two major deposits, is focused on accelerating exploration efforts at its properties as well as furthering development. This may positively influence shareholder value.

Sitka Gold (SITKF), closed Wednesday's trading session at $0.155, up -2.8822%, on 193,000 volume with 00 trades. The average volume for the last 3 months is 4,674 and the stock's 52-week low/high is $0.065 /$0.17 .

Urbanimmersive (UBMRF)

We reported earlier on Urbanimmersive (UBMRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Urbanimmersive Inc. (OTCQB: UBMRF) (CVE: UI) (FRA: 2V6A) is a company focused on developing and commercializing real estate photography technologies and services.

The firm has its headquarters in St. Hubert, Canada and was incorporated in 2007, on July 1st by Ghislain Lemire. It operates as part of the software-application industry, under the technology sector. The firm mainly serves consumers in Canada.

The company which is focused on innovating cost-effective business management solutions, empowers photographers to build successful businesses, and real estate agents to enhance their listings with visually captivating and detailed property presentations.

The enterprise operates as a software as a service (SaaS) platform offering immersive marketing solutions, three-dimensional (3D) photographic equipment and photography services to professional photographers. Its segments include Software, Photographic Equipment and Services. The Software segment provides a SaaS marketing platform to professional photographers and other immersive visual content providers. The Photographic Equipment segment provides a resale service of 3D photographic equipment. On the other hand, the Service segment provides real estate photography and floor plans and measurement services. The enterprise’s products and services include Print, Visual Media, Property Website, Floor Plan + and 3D Tour & Floor Plan. Through its HomeVisit printing facilities, it offers print solutions for real estate agents.

The firm recently announced its engagement of U.S. investment bank, Joseph Gunnar & Co. LLC, for capital market advisory and investment banking services. It plans to use the funds raised to improve its market visibility, broaden its access to capital in the United States and generate value for its shareholders.

Urbanimmersive (UBMRF), closed Wednesday's trading session at $0.0889, up 0%, on volume with 00 trades. The average volume for the last 3 months is 9,176 and the stock's 52-week low/high is $0.033 /$0.21868 .

Orvana Minerals (ORVMF)

We reported earlier on Orvana Minerals (ORVMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Orvana Minerals Corp. (OTC: ORVMF) (TSE: ORV) (FRA: O6M) is a mining and exploration firm focused on evaluating, developing and mining gold, silver, copper and other precious and base metal deposits.

The firm has its headquarters in Toronto, Canada and was incorporated in 1992, on February 24th. It operates as part of the other precious metals and mining industry, under the basic materials sector. The firm serves consumers primarily in Canada.

The company operates as a subsidiary of Fabulosa Mines Ltd. It predominantly operates in the gold and copper mining industry and its main products are gold dore and gold/copper concentrates. The company's segments include Empresa Minera Paititi S.A, which operates Don Mario Mine in Bolivia; Orovalle Minerals S.L., which operates El Valle Mine in Spain; Orvana Argentina; and Corporate. It generates the majority of its revenues from the Orovalle Minerals S.L. segment.

The enterprise’s properties include the El Valle and Carles mines, which are situated in Asturias, Northern Spain. It also owns the Don Mario Operations in San Jose de Chiquitos, Southeastern Bolivia. The property is made up of roughly 10 contiguous mineral concessions that cover about 53,325 hectares (ha). In addition to this, the enterprise owns the Taguas Property, which is situated in the Province of San Juan, Argentina. This property comprises of approximately 15 mining concessions that cover about 3,273.87 ha.

The firm, which recently announced its latest financial results, is focused on expanding its Don Mario plant and scaling up its production. This will, in turn, positively influence revenues and investments into the firm as well as shareholder value.

Orvana Minerals (ORVMF), closed Wednesday's trading session at $0.1281, up -10.4196%, on 27,300 volume with 00 trades. The average volume for the last 3 months is 6,007 and the stock's 52-week low/high is $0.1006 /$0.195 .

Nanophase Technologies (NANX)

QualityStocks, SmarTrend Newsletters, CoolPennyStocks, HotOTC, MarketBeat, Profit Confidential, Wall Street Resources, Stock Rich, Schaeffer's, Stealth Stocks, BullRally, PoliticsAndMyPortfolio, Penny Invest, Investment Contrarians, StockEgg, Wall Street Mover and RedChip reported earlier on Nanophase Technologies (NANX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nanophase Technologies Corporation (OTCQB: NANX) is a company engaged in the provision of engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the U.S.

The firm has its headquarters in Romeoville, Illinois and was incorporated in 1989, on November 25th by Richard W. Siegel. It operates as part of the specialty chemicals industry, under the basic materials sector. The firm mainly serves consumers in the United States.

The company has evolved from solely a producer of nanoparticles into an integrator of commercially scaled nanomaterial technologies focused on market and customer applications. It has the capabilities to make, coat and disperse nano metal oxides and offers consumers a solution approach for applications. The integrated family of nanomaterial technologies forms its core intellectual property and proprietary knowledge. Currently, the company owns or licenses 18 United States patents and patent applications, and 48 foreign patents and patent applications.

The enterprise produces engineered nanomaterial products from antimony, bismuth, cerium, iron, and zinc oxide formulation for use in a range of markets, including exterior coatings, energy storage, textiles, integrated circuit and data storage, plastics, personal care, and optical surface polishing. It also manufactures skin health products, including sunscreens and daily care products under the Solésence brand name; and advanced material products, including industrial coatings, architectural coatings, plastics additives, abrasion-resistant additives, and medical diagnostics.

The firm recently reported its latest financial results, with its CEO noting that the company was positioned for success and was focused on improving its production capabilities and bolstering its overall growth.

Nanophase Technologies (NANX), closed Wednesday's trading session at $0.55, up -8.3333%, on 10,700 volume with 00 trades. The average volume for the last 3 months is 260,811 and the stock's 52-week low/high is $0.32275 /$1.80 .

TerrAscend Corp. (TSNDF)

QualityStocks, InvestorPlace and Cabot Wealth reported earlier on TerrAscend Corp. (TSNDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

September saw Arizona’s marijuana sales surpass $1 billion for the year following a pattern that both recreational and medical markets seemed to have stabilized over the previous few months. The state’s revenue department (ADOR) data for August and September reveals a consistent pattern, with medical sales remaining around one-third of recreational sales.

September’s medical sales were marginally below $27 million, down from $28.7 million in August. This represents the lowest in medical sales since the legalization of recreational marijuana in 2021. The last time medical sales surpassed $30 million was in June, and they have been consistently declining from the peak of $73.4 million in April 2021.

Contrastingly, recreational sales have remained robust, consistently surpassing $80 million since dropping below $90 million in May. August reported recreational cannabis sales at $85.8 million, followed by slightly more than $80 million in September. The recreational market has only failed to reach the $80 million mark twice —in May and June of 2022 at $79.3 million and $77.2 million, respectively.

However, those figures could alter because ADOR often modifies the figures from previous months with new reports. For example, the most recent announcement from ADOR raised July’s medical sales from $26.1 million to $27.3 million, while recreational sales changed from $77.4 million to $80.5 million.

As of September 2023, total medical marijuana sales for the year reached $267 million, while recreational sales amounted to nearly $797 million, culminating in a year-to-date total of almost $1.1 billion. Since the commencement of recreational cannabis sales in 2021, the industry has generated more than $4 billion, with approximately $2.5 billion attributed to adult-use sales.

The state has collected substantial taxes from both sectors, with $2.2 million and $2.4 million from medical cannabis sales in September and August, respectively, and $12.8 million and $13.7 million from recreational sales. Arizona applies a standard sales tax of 5.5% and a 16% excise tax on recreational sales. Medical patients only foot the standard 5.5% sales tax. Local jurisdictions add roughly 2% to all cannabis sales.

Around $174.5 million has been collected thus far in 2023 from the recreational sales excise tax. In 2021, recreational marijuana generated $33 million, and in 2022, the figure surged to $132.7 million. Since recreational cannabis legalization, the state has amassed more than $392 million in cannabis excise taxes.

The tax revenues are allocated to various sectors: 10% goes toward the justice reinvestment fund, which supports communities disproportionately impacted by cannabis criminalization; 34% goes toward community colleges; 31% goes toward public safety; and 25% goes to the Arizona Highway User Fund.

There were 121,047 qualified cannabis patient cardholders as of October 2023, compared to 123,795 in September. Before the introduction of recreational cannabis, there were 299,055 qualifying patients. The report also noted that 4,475 pounds of cannabis were purchased for medical purposes in October, down from 4,622 in September, bringing the total for the year as of October to 47,076 pounds.

The thriving marijuana industry in Arizona in a way depicts what is happening in many markets in which regulated cannabis sales are allowed and companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) obtain licenses to commercialize innovative cannabis products.

TerrAscend Corp. (TSNDF), closed Wednesday's trading session at $1.37, up 0%, on 238,276 volume with 00 trades. The average volume for the last 3 months is 5.894M and the stock's 52-week low/high is $1.00 /$2.3407 .

Canaan Inc. (CAN)

QualityStocks, MarketClub Analysis, Schaeffer's, InvestorPlace, StockEarnings, TradersPro, StreetInsider, Stockhouse, MarketBeat, AllPennyStocks, CryptoCurrencyWire, INO Market Report, BUYINS.NET, InvestorsUnderground, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Despite being apprehensive about the cryptocurrency markets in the upcoming year, JPMorgan anticipates that Ethereum will surpass Bitcoin and other digital currencies in 2024. According to JPMorgan analysts, ether is poised for a resurgence and a recapture of market share within the crypto ecosphere.

The primary driving force behind the growth is the anticipated Proto-danksharding, or EIP-4844 upgrade, which is scheduled for the first half of next year. The analysts believe that Proto-danksharding will play a substantial role in improving ether’s network activity, positioning it for superior performance.

Proto-danksharding is the first step toward the implementation of Danksharding, a more sophisticated kind of sharding intended to increase Ethereum’s efficiency. In contrast to the original sharding method, Danksharding avoids the laborious task of splitting Ethereum into several shard chains. Rather, it presents data blobs, which are transient data packets attached to blocks. The Ethereum virtual machine can access and store more data in these blobs than in blocks, but they are not kept indefinitely.

This update is especially helpful for layer 2 networks on Ethereum, such as Optimism and Arbitrum, because it offers more temporary data capacity to boost network throughput and lower transaction costs.

The analysts assert that factors perceived as bullish for Bitcoin in the coming year, such as potential spot ETF approvals and an impending halving, are already factored into the current market dynamics. Drawing comparisons to the 2020 halving, they suggest that a similar market price-to-production cost ratio adjustment may occur after the 2024 halving.

Addressing decentralized finance (defi), the analysts expressed disappointment in its struggle to integrate into the traditional financial system. They emphasized the necessity of bridging the gap between the crypto ecosystem and real-world applications for the broader adoption of blockchain technology in traditional finance.

Furthermore, they expressed reservations about the slow evolution of tokenization, labeling it as largely experimental and hindered by fragmentation, lack of cooperation and interoperability between platforms. The researchers highlighted delays in the introduction of central bank digital currencies by the European Central Bank and the Federal Reserve, coupled with a lack of regulations, as additional obstacles.

While the fourth quarter witnessed a modest improvement in venture capital funding in the cryptocurrency space compared to the rest of the year, analysts remain cautiously optimistic. They assert that if this positive trend continues into 2024, it would signify a substantial development and, in their opinion, mark the end of the cryptocurrency winter.

The overriding sentiment in these predictions is a positive one, and established companies such as Canaan Inc. (NASDAQ: CAN) can only hope that the tailwinds that manifested as 2023 progressed carry on into the coming year so that the industry puts the challenges of the recent upheavals behind it.

Canaan Inc. (CAN), closed Wednesday's trading session at $2.57, up 15.2466%, on 50,981,752 volume with 00 trades. The average volume for the last 3 months is 607,080 and the stock's 52-week low/high is $1.13 /$3.98 .

Seelos Therapeutics Inc. (SEEL)

QualityStocks, MarketBeat, StockEarnings, StockMarketWatch, MarketClub Analysis, TradersPro, Schaeffer's, BUYINS.NET, Trades Of The Day, Prism MarketView and INO Market Report reported earlier on Seelos Therapeutics Inc. (SEEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Some Kentucky advocates are considering the idea of exploring ibogaine, a relatively unknown psychedelic drug, as a potential treatment for opioid addiction. The Kentucky Opioid Abatement Advisory Committee is thinking of funding ibogaine research as part of efforts to combat the spiraling opioid epidemic and save countless lives.

America has been in the grip of an opioid epidemic and has lost hundreds of thousands of people to opioid overdoses over the past two decades. Opioids have been the main treatment option for chronic pain conditions for several decades due to their incredible pain-relieving capabilities. However, they have an extremely high risk of dependence and addiction, causing many chronic pain patients to develop addictions that can become destructive and fatal.

Researchers have invested considerable time and funds into developing safer alternative pain relief medications for quite some time. Psychedelics, a class of outlawed drugs that have primarily been used recreationally for their hallucinatory effects, are now attracting considerable attention due to their potential mental-health benefits. This includes treating mental conditions such as substance use disorder, depression, anxiety and post-traumatic stress disorder (PTSD).

Ibogaine is extracted from a shrub called “iboga” that typically grows in Central Africa and is currently outlawed in the United States. However, the psychedelic has gained immense popularity in Mexico, where it is legal, as an alternative therapy for opioid-use disorder. However, unlike psychedelics such as psilocybin, which are relatively harmless even when taken recreationally, ibogaine can be deadly when taken without medical supervision.

Even so, the psychedelic has shown some promise as an alternative treatment for opioid addiction. Genís Oña, a researcher at International Center for Ethnobotanical Education, Research and Service, says we need better research to broaden our understanding of how ibogaine works.

Kentucky’s state opioid committee is planning to vote on whether or not the state should begin funding this ibogaine research. If the committee approves this move, $42 million of the nearly $840 million received as settlements from drug makers, distributors and pharmacies would be allocated to studying ibogaine therapy. This research would give scientists significant insight into the safety and efficacy of ibogaine therapy for opioid addiction at a time when America desperately needs such therapies.

Opioids were significantly responsible for the more than 100,000 overdose deaths that occurred in 2020, and Kentucky ranks second nationally in terms of drug-overdose deaths. Data from the Centers for Disease Control and Prevention also shows that the state has a drug-overdose death rate of 55.6 per 1,000 deaths and is only surpassed by West Virginia, which has an overdose death rate of 90 per 1,000 people.

While Kentucky considers funding studies to establish the efficacy of ibogaine in addressing opioid addiction, many startups such as Seelos Therapeutics Inc. (NASDAQ: SEEL) are focusing on developing a catalog of psychedelic-based treatments for several mental-health issues, including PTSD, depression and substance abuse.

Seelos Therapeutics Inc. (SEEL), closed Wednesday's trading session at $1.475, up -8.3851%, on 365,819 volume with 00 trades. The average volume for the last 3 months is 4.417M and the stock's 52-week low/high is $1.04 /$49.80 .

VinFast Auto Ltd. (VFS)

Schaeffer's, MarketBeat, Early Bird, QualityStocks and InvestorPlace reported earlier on VinFast Auto Ltd. (VFS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tesla has announced a partnership with rideshare company Uber that will see the Texas-based EV maker offer discounts of up to $3,000 to Uber drivers. According to the deal, Uber drivers will be able to purchase the Tesla Model Y and Model 3 at discounted prices directly from Tesla on Uber’s vehicle marketplace platform.

The recent partnership is one of the many electrification endeavors undertaken by fleets in the United States. While Uber doesn’t own the majority of the vehicles used on its rideshare platform, the company is committed to facilitating electric- vehicle adoption among its drivers. Partnering with Tesla will grant Uber drivers access to bestselling electric cars at reduced prices based on their driver rating.

For instance, drivers with blue and gold ratings will qualify for a $1,000 discount with the purchase of an eligible Tesla model and completion of 100 rideshare trips in the electric car. These drivers must have received their EV in December 2023 and completed 100 rideshare trips before Feb. 25, 2024, to qualify for the discount.

Platinum drivers will be eligible for a $2,000 discount while diamond drivers qualify for a $3,000 discount with the purchase of an eligible Tesla. Both classes of drivers will also be subject to the same rules as blue and gold drivers.

It seems that both Tesla and Uber are financing the discounts, which will cover Tesla models delivered by December 2023. Tesla is currently scrambling to deliver as many electric cars as possible before the year ends as part of the company’s efforts to reach the goal of delivering 1.8 million cars this year and breaking sales numbers. Unfortunately, Tesla sales in major markets such as China, Europe and the United States have declined in recent months.

High prices coupled with surging interest rates have forced drivers in most markets to opt for cheaper alternatives or put off purchasing an EV altogether. Significantly increased competition in China has also caused Tesla to lose market share to local automakers and forced it to engage in price discount wars to remain competitive.

Furthermore, tighter electric-vehicle subsidy policies in European nations such as Germany and France will likely cause Tesla sales to slump in the EU region. The requirement to complete 100 rideshare trips by mid-February to qualify for the discount would also benefit Uber because it will keep drivers on the platform and allow the rideshare company to cut emissions from its vehicles.

Other automakers in the EV space such as VinFast Auto Ltd. (NASDAQ: VFS) may also be considering strategies to boost their sales to fleets around the world in a bid to shore up sales and win market share.

VinFast Auto Ltd. (VFS), closed Wednesday's trading session at $7.94, up -0.75%, on 6,434,311 volume with 00 trades. The average volume for the last 3 months is 435,238 and the stock's 52-week low/high is $4.59 /$93.00 .

Alliance Resource Partners LP (ARLP)

The Online Investor, Zacks, QualityStocks, TradersPro, The Street, MarketBeat, InvestorPlace,, MarketClub Analysis, DividendStocks, TopStockAnalysts, The Wealth Report, Dividend Opportunities, TheStockAdvisor, MiningNewsWire, StreetAuthority Daily, Money Morning, The Motley Fool, Market Intelligence Center Alert, Early Bird, BUYINS.NET, Wealth Insider Alert, The Growth Stock Wire, TraderPower, Investing Daily, Trading Concepts, TheStockAdvisors, TheOptionSpecialist, Rick Saddler, Daily Wealth, SmarTrend Newsletters, Daily Trade Alert, Louis Navellier, Daily Markets, FNNO Newsletters, FreeRealTime, Greenbackers, Insider Wealth Alert, Eagle Financial Publications, Investment U, Investor Update,, Leeb's Market Forecast, Top Pros' Top Picks, TheTradingReport, TheStreet Offers, Money and Markets, Short Term Wealth, StockEarnings, StreetInsider and Trades Of The Day reported earlier on Alliance Resource Partners LP (ARLP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The International Energy Agency recently released its latest report, which shows that the use of coal globally will hit new highs this year as demand in developing and emerging economies continues to grow. The report comes just days after the end of the COP28 United Nations Climate Summit, which was held in Dubai. The final agreement at the summit centered on accelerating efforts toward phasing out of coal for power generation.

Despite campaigns to adopt cleaner energy sources, however, coal remains the largest source of power generation globally. This fossil fuel is the primary source of power for industries such as cement and steel. Figures show that this year, coal demand is growing by 1.4%, which exceeds 8.5 billion metric tons. This can be attributed to demand from China and India primarily, whose coal use has grown by 5% and 8% respectively as a result of weak output of hydropower and increasing demand for power.

Globally, the use of this fossil fuel isn’t expected to decline until 2026.

It is expected that in the next three years, renewable energy capacity will have grown significantly, which could help reduce the use of coal by 2.3% in comparison to current levels. Despite this, forecasts show that coal consumption globally will remain more than eight billion metric tons in 2026. Those levels will make it harder to achieve the goals set in the Paris Agreement, which call for the reduction of emissions and the acceleration of clean-energy use.

The report highlighted that one-half of the coal used worldwide came from China, which meant that coal’s outlook will be impacted considerably in the coming years by structural shifts, weather conditions and the rate at which clean energy is being deployed in China’s economy. Projections indicate that looking forward, India, China and southeast Asia are expected to make up more than one-half of the worldwide consumption of coal. This is quite an increase, with southeast Asia’s consumption expected to eclipse the European Union and the United States in 2023.

The report shows that in the U.S. and EU, the use of coal will decline by about 20% respectively.

Up until 2026, southeast Asia and India are the main regions where the consumption of coal is expected to significantly grow. This underscores just how vital coal producers such as Alliance Resource Partners LP (NASDAQ: ARLP) still are in the global energy mix despite the current push to phase out coal.

Alliance Resource Partners LP (ARLP), closed Wednesday's trading session at $19.62, up -1.3078%, on 272,950 volume with 00 trades. The average volume for the last 3 months is 2.91M and the stock's 52-week low/high is $17.05 /$24.30 .


InvestorPlace, Schaeffer's, StockEarnings, StocksEarning, QualityStocks, MarketBeat, Trades Of The Day, Daily Trade Alert, BUYINS.NET, The Street, Kiplinger Today, The Online Investor, StreetInsider, Early Bird, CNBC Breaking News, FreeRealTime, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Recent data shows that officials in the state of Missouri have thus far expunged more than 100,000 cannabis cases from court records. Under the law, misdemeanors had to be automatically expunged by June 8, 2023, and felonies had to be cleared by Dec. 8, 2023. The deadline for felony expungements, which lapsed last week, wasn’t met by all courts, however, with clerks still reviewing decades of old cases.

In an interview, Dan Viets, a lawyer and coordinator of Missouri NORML, stated that courts would need additional time to finish the task and noted that it could be years before all cases from the last 100 years were expunged. Viets, who also coauthored the state’s constitutional amendment legalizing cannabis, added that the state had prohibited cannabis for more than a century and, given that most older cases hadn’t been updated on a database, a lot of physical work was needed to find and go through hard-copy records.

In a press release of the state’s NORML chapter, Viets noted that the provision on automatic expungement was a significant part of Missouri’s marijuana law that was approved by voters in 2022. Missouri NORML also highlighted that the ballot proposal, now codified as Article XIV in the state’s constitution, provided funds for the expungement via the 6% sales tax imposed on recreational cannabis.

The organization explained that the tax had generated more revenue than was needed to pay overtime to existing staff or fund the hiring of more staff in the offices of circuit clerks across Missouri. In November, total cannabis sales in the state exceeded the $1 billion mark, with legislators announcing recently that of the total taxes generated, $17 million would fund drug treatment, veterans’ health and legal aid.

Viets also noted that counties that missed the December deadline were in violation of Missouri’s constitution and legal action could be taken. He then revealed that about six of the counties in the state hadn’t expunged any cases on misdemeanor violations, asserting that these were smaller counties where Amendment 3’s support wasn’t as high.

On a broader scale, the state’s cannabis system has experienced significant hitches this year, with thousands of products being recalled over the illegal use of cannabinoids derived from hemp. In November, officials revoked Delta Extraction’s business license, as the company was at the center of the aforementioned dispute.

Another company, Retailer Point Management, also had to settle a dispute with a union over more than 10 charges of unfair labor practices. All this is part of a wider push by workers at marijuana businesses to organize the industry.

These ongoing expungements are likely being watched closely by the entire cannabis industry, including companies such as SNDL Inc. (NASDAQ: SNDL), given that times have changed and there is a growing consensus that no one should suffer lifelong consequences for being convicted after using a substance that is now legal in a significant portion of the United States as well as several countries around the world.

SNDL Inc. (SNDL), closed Wednesday's trading session at $1.42, up -1.3889%, on 4,577,223 volume with 00 trades. The average volume for the last 3 months is 162 and the stock's 52-week low/high is $1.25 /$2.48 .

The QualityStocks Company Corner

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Diamond Lake Minerals (OTC: DLMI), a leading multistrategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, was featured in a recent exclusive Benzinga interview. During the interview, Diamond Lake Minerals CEO Brian Esposito talked with host Michael Murry about the company, which specializes in the development and support of digital assets and SEC-registered security tokens. During the interview, Esposito discussed how Diamond Lake Minerals is bridging traditional finance with a digital future. Esposito noted that DLMI is focused on building strong companies with sustainable earnings. "Bu more importantly and what's making us pretty unique and [putting] a nice spotlight on us is that we're going to be having security token offerings with our partner INX throughout all our subsidiaries and business units, so we're combining traditional securities with the future of digital assets in a regulated environment," said Diamond Lake Minerals CEO Brian Esposito in the interview.

"We're solely focused on a regulated environment and digital securities and security tokens. So what I have felt that's missing in this world as far as the wealth of the world that's sitting on the sidelines that don't understand things like crypto, they don't understand digital assets. They don't understand NFTs. A lot of friction points. They don't believe it's real. They're intimidated by downloading a digital wallet, putting in personal information. So what we're doing as a hybrid approach is that we're doing something that people are very familiar with, and that is buying a stock. So now they can be part of this entire wonderful digital industry by looking at stocks hopefully like ours and hopefully more that come to market and saying, yes, I am in that space. I own DLMI stock. I'm in digital assets. I'm in digital securities, without the friction points. . . . I think this is what is going to allow people to understand that this is the movement that is happening. It is real. . . And we want to be that stock that is an authority in the space. We want to be that company that shows the world how to do it. And we want to be that company that other public companies emulate and replicate our model and what our structure is."

To view the full interview, visit

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Wednesday's trading session at $4.9, up 3.1579%, on 130 volume with 00 trades. The average volume for the last 3 months is 30,106 and the stock's 52-week low/high is $0.35 /$4.90 .

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Canadian metals supply company Ucore Rare Metals Inc. is focused on establishing North American independence in the production of rare earth elements ("REEs") vital to modern computerized technologies

China currently dominates the global market for mining, processing and product creation for REEs, raising concerns that governmental controls over its industries could hamstring supplies Western nations need for everything from cell phones to fighter jet parts

Ucore is preparing to establish commercial operations for REE refining and processing using the company's trademarked RapidSX(TM) solution, which has demonstrated significant economical and environmental improvement over the standard SX separation technology

The company recently announced execution of a tax exemption contract in Louisiana, where it will build the first commercial facility, and the company has selected initial construction contractors to get the process under way

Strategic metals enterprise Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is wrapping up the year by presenting its shareholders a soft construction launch for work at the Louisiana site where the company will build its important rare earth element ("REE") processing plant.

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX™, for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated by China.

China currently controls about 80% of the world’s access to REE mining projects and over 90% of the world’s REE processing capabilities, and it produces about 95% of the goods containing REE components.


Ucore is working to scale Western supply needs by establishing REE separation and rare earth oxide (“REO”) production capabilities in cooperation with strategic upstream supply and downstream offtake partnerships. The company, along with its industry partners, aims to unlock access to Western REEs for current consumer, energy, manufacturing and military sectors.

By 2025, Ucore expects to commercially separate U.S.-friendly sources of REEs and supply OEMs with REOs required to produce rare earth permanent magnets (“REPMs”) – the essential component of electric motors and generators required to support the world’s transition to electrification and sustainable energy sources.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

The company has three initial U.S.-friendly feedstock agreements in place for the Louisiana complex, along with multiple developing offtake agreements. It received a C$16 million+ incentive package offer from Louisiana Economic Development to support construction of the SMC.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Wednesday's trading session at $0.5914, up 3.8272%, on 47,851 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $4.90 /$.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2023 annual general meeting. According to the report, during the meeting, which was held on Dec. 19, 2023, all matters considered by shareholders were approved; agenda items were sent to shareholders in a notice of meeting and management information communication that was released on Oct. 27, 2023. In addition, shareholders approved the election of five directors, including Eric A. Adams, Janet Grove, Andrew Hull, Nicole Lemerond and Bryan Baldasare; directors will hold their office until the next annual meeting or until successors are elected and appointed. The company noted that 1,292,647 common shares of the company were represented at the meeting, either in person or by proxy, which represents almost 39% of the company's 3,328,191 issued and outstanding shares.

To view the full press release, visit

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.


The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Wednesday's trading session at $0.3641, up 5.5362%, on 2,916,342 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2913 /$3.03 .

Recent News

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF)

The QualityStocks Daily Newsletter would like to spotlight Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) .

Reunion Gold Corporation (TSXV: RGD; OTCQX: RGDFF) (the " Company ") announced today that, further to its news release of February 13, 2023, it has settled the claim brought by Barrick Gold Corporation (" Barrick ") on a mutually acceptable basis. The Company and Barrick have agreed that the Strategic Alliance Agreement entered into by them on February 3, 2019 has been terminated. The parties have no outstanding obligations under the Alliance Agreement, and there are no properties subject to the Alliance Agreement. A consent dismissal order will be entered in the Ontario Superior Court to dismiss the claim.

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) is a leading gold explorer in the Guiana Shield, South America. In early 2021, the Company announced an exciting new greenfield gold discovery at its Oko West project in Guyana, where, after 22 months of resource definition drilling, the Company has announced an initial Mineral Resource Estimate (MRE) containing 2.475 Moz of gold in Indicated resources at 1.84 g/t and 1.762 Moz of gold in inferred resources at 2.02 g/t contained within a pit shell outline. Preliminary metallurgy results performed by the company, consisting of 8 bottle roll tests obtained strong results, averaging just under 90% recoveries on average. The Company is continuing with additional development activities at Oko West, including environmental base line studies and additional metallurgical work relating to the delivery of a PEA by year end 2023. In addition, Reunion Gold is currently exploring several priority targets in the Oko West project area on which the company feels there is good potential to add additional resource ounces. This includes the opportunity to grow the initial mineral resource estimate (MRE) released on June 13, 2023, and to discover additional gold ounces at Oko West outside of the resource area.

The Guiana Shield remains one of the most prospective exploration locations globally for the discovery of world class orogenic gold deposits. The shield, including both Guyana and Surinam, contain large relatively underexplored greenstone belts, from which Reunion Gold expects many more significant gold discoveries could emerge in the coming years.

Oko West Project

Reunion Gold’s Oko West Project is a brand-new gold discovery in northwest Guyana located within the historical Oko gold district. Alluvial gold has been mined from the Oko district since the turn of the century, but very little primary gold has been mined or even explored for to the best of the company’s knowledge. The project comprises a prospecting license with an area of approximately 44 square kilometers and is 100% held by Reunion’s Guyanese subsidiary.

In 2020, Reunion Gold’s geochemical survey, trenching and initial 1000 m drill program discovered and confirmed the presence of gold mineralization in this Orogenic gold system. The gold occurs in the eastern edge of the project area, along a 6km long sheared contact between a granitoid intrusion and a meta volcanic-meta sedimentary rock package. The MRE is located within the Kairuni zone, which represents the northern most 1.9 km of the 6 km long contact.

“We are advancing our Oko West project along two tracks. The first is to advance the exploration programs outside of the Kairuni zone, aimed at outlining and discovering additional gold mineralization within our Prospecting License. On this front, I am very excited by the results from the initial Scout RC Geochem drill program that is defining new targets west of our Kairuni zone,” Rick Howes, President and CEO of Reunion Gold, stated in a recent news release. In addition to the targets west of the Kairuni zone, the company has also commenced exploration work on the southern ~ 4 km of the same sheared contact that hosts the Kairuni zone MRE. In addition, the company feels that the MRE marks the size of the Kairuni resource at a point in time and that there is good potential to continue to grow the resource. The MRE remains open at depth below the resource pit outline in the block 4 area and also to depth and along strike in the block 5 and 6 areas. In addition to the exploration programs, the second strategic track is to rapidly advance the Kairuni zone along the path to development. To that end the company is moving forward with the engineering and other studies, including more detailed metallurgical studies, that will support the release a PEA on the Kairuni zone by year end 2023 The company feels that the rapid advancement of development of Kairuni zone MRE, while in parallel continuing to explore for additional ounces on the project, is the best path to try and maximize shareholder value in the shortest period of time.


Guyana boasts a long history of mining gold, bauxite, diamonds and manganese. Still, the greenstone belts of the Guiana Shield remain relatively unexplored when compared to the analogous regions of the West African Shield (Birimian), which, according to geological evidence, was once connected to the Guiana Shield, forming a contiguous craton prior to the Mesozoic period.

Despite a historical lack of accessibility and low exploration intensity, several significant large-scale projects have emerged in the Guiana Shield, including Aurora, Oko West, Oko Main, Toroparu and Omai. Guyana is English speaking with a British based parliamentary and legal system and boasts the world’s fastest growing economy on the back of significant offshore oil discoveries by Exxon and its partners. It is expected that a significant amount of the revenues from oil production will be invested in improving the infrastructure, education and health care and agriculture within the country.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, called 2022 the “strongest year for gold demand in over a decade.” Annual gold demand jumped 18% YoY due to “colossal central bank purchases, aided by vigorous retail investor buying and slower ETF outflows.”

Despite this spike in demand, total annual gold supply increased by just 2% in 2022, halting two years of successive declines but failing to challenge 2018 highs. This supply-demand imbalance could provide a favorable market environment as Reunion Gold continues to advance drilling programs at its 100%-owned Oko West Project.

Management Team

Successful exploration and the discovery of significant deposits in any given region require immense amounts of local knowledge and experience. This is the principle around which Reunion Gold has built its management team. In total, the company’s leadership boasts over 225 years of combined experience in the Guiana Shield.

David Fennell is the Executive Chairman of Reunion Gold, a position he has held since the company’s inception in 2003. He has 40 years of experience in the mining industry. He received a law degree from the University of Alberta in 1979 and practiced law until he founded Golden Star Resources Ltd. in 1983. During his term as President and CEO, Golden Star became one of the largest and most successful exploration companies. While at Golden Star, he was instrumental in the discovery and development of the Omai Gold Mine in Guyana and the Gross Rosebel Mine in Suriname. In 1998, Mr. Fennell became Chairman and CEO of Hope Bay Gold Corporation. He held this position through the merger of Hope Bay and Miramar Mining Corporation and remained as Executive Vice-Chairman and Director for the combined entity until its takeover by Newmont Mining Corporation in 2008. Mr. Fennell is currently a member of the board of directors of G Mining Ventures Corp. and Sabina Gold & Silver Corp.

Rick Howes, P.Eng., is the company’s President and CEO. He is a seasoned mining executive with over 39 years of experience in the mining industry, most recently as CEO of Dundee Precious Metals. Mr. Howes has extensive operating, technical and project development experience in both underground and open pit mines throughout Canada and internationally. In 2009, Mr. Howes joined Dundee Precious Metals, where, as VP and General Manager, he led the transformation of the Chelopech Mine in Bulgaria to reach world-class levels of performance. He became COO in 2011 and oversaw several significant growth capital development projects, including the expansion of the Chelopech Mine, the upgrade and expansion of the Tsumeb Smelter in Namibia and the development of the greenfield Ada Tepe open pit gold mine in Bulgaria. He was appointed CEO in April 2013, leading Dundee’s transformation from a junior gold producer to a multi-asset mid-tier gold producer generating strong free cashflow and solid returns to shareholders. Mr. Howes has been recognized as a visionary leader in mining, organizational innovation and transformation and was recognized as the Outstanding Innovator of 2016 by the International Mining Technology Hall of Fame.

Alain Krushnisky is the CFO of Reunion Gold. He brings to the company years of experience in the mining sector, including 10 years with Cambior Inc. (now IAMGOLD) in capacities such as Vice-President and Controller. Since 2004, Mr. Krushnisky has been doing consulting work for various publicly listed exploration and mining companies. He graduated from the University of Ottawa in 1983 with a bachelor’s degree in commerce and is a Chartered Professional Accountant.

Justin van der Toorn is the company’s VP Exploration. He is an exploration geologist with 18 years’ experience in the minerals industry, leading and managing exploration teams from grassroots activities through to discovery and resource definition drilling. Mr. van der Toorn’s previous experience has been in a range of commodity and deposit styles, including extensive work in Carlin-style gold, low- and high-sulphidation epithermal, porphyry and orogenic gold systems. He holds an MSci degree in Geological Sciences from the Royal School of Mines, Imperial College London. He is registered as a Chartered Geologist (CGeol) of the Geological Society, and a European Geologist (EurGeol) by the European Federation of Geologists.

Doug Flegg is the company’s business Development advisor. Doug has over 35 years’ experience in mining and mining finance with senior positions in research, portfolio management and global equity sales. Previously, Mr. Flegg was Managing Director Global Mining Sales with BMO Capital Markets where he was involved in raising $35 billion in over 200 corporate financings. Since 2016 he has been providing business development, strategic, and financing advice to corporate mining clients. Mr. Flegg also has a B.Sc. in Geology, work experience as a geologist and an MBA from Queens University.

Reunion Gold Corp. (OTCQX: RGDFF), closed Wednesday's trading session at $0.33645, up 1.9545%, on 962,425 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2123 /$0.46 .

Recent News

Starco Brands Inc. (OTCQB: STCB)

The QualityStocks Daily Newsletter would like to spotlight Starco Brands Inc. (OTCQB: STCB).

Starco Brands (OTCQB: STCB), developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, today announced an in-depth update on the performance of its business unit, Skylar, maker of clean fragrances. Acquired in January 2023, Skylar has seamlessly integrated into the Starco Brands portfolio and marked a historic milestone by recording its most profitable quarter ever in Q3 2023.

"We are thrilled with Skylar's extraordinary performance since joining the Starco Brands family. This success story is a testament to our strategic vision and the team's relentless pursuit of innovation and excellence. Skylar's record-breaking quarter is not just a milestone for the brand but a clear indication of our ability to identify and cultivate brands with immense potential," said Ross Sklar, CEO of Starco Brands. "Our focus on synergizing operations, optimizing marketing strategies, and strengthening retail partnerships has been instrumental in this achievement. As we continue to grow, we remain committed to Skylar's core values of sustainability and well-being, ensuring that every step is a stride towards a better future for our modern, conscientious consumer and our planet."

Key Highlights:

Unprecedented Growth: Since the acquisition of Skylar ten months ago, Starco Brands has successfully transformed Skylar into a profitable entity, substantially enhancing the company's revenue and contributing positively to its synergized adjusted EBITDA.

Record-Breaking Quarter: The third quarter of 2023 was Skylar's most profitable ever, driven by innovative marketing strategies, optimized marketing spend, strategic headcount adjustments, and robust sales growth.

Explosive Sales Performance: In Q3 2023, Skylar experienced a remarkable revenue increase, doubling its sales on Amazon and witnessing a surge of over 45% at Sephora compared to the previous year's corresponding period.

Starco Brands Inc. (OTCQB: STCB) is a modern-day invention factory. The company’s unwavering mission is to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

This consumer product company has grown from a few million dollars in revenue to a current run rate of approximately $67 million in annual revenue in one year.

The company has succeeded by identifying whitespaces in eight core consumer categories and then either: 1) leveraging its internal R&D capabilities and dedicated manufacturing network to invent new technologies and brands or 2) utilizing the management team’s extensive M&A experience to acquire brands that fill the industry void, delighting consumers and retailers alike.

Whether the brand is developed internally or acquired, the company employs a modern marketing playbook to ensure its brands are at the forefront of culture; garnering unprecedented media attention and engagement that supports a robust sales network.

Starco Brands’ core competencies are inventing technologies, acquiring companies, marketing, building trends, pushing awareness, penetrating media (social and otherwise) and executing cutting edge pull-through strategies with a roster of globally recognized celebrities, influencers and media and distribution partners.

A commitment to changing the way people approach everyday activities is innate in the company’s corporate DNA.

The company is based in Santa Monica, California.


Whereas other consumer products companies are content with evolution, Starco Brands has its mind set on creating a revolution across the industry. From disrupting the spirits industry with Whipshots, the world’s only vodka-infused whipped cream, to Soylent, the original food tech company, Starco Brands is putting the CPG world on notice. Its portfolio of brands includes:

  • Whipshots is a first-of-its-kind alcoholic whipped cream launched in 2021 with celebrity partner Cardi B. Consumers have embraced this boozy concoction, putting it on top of cocktails, coffees and desserts, or enjoying it straight from the can. In just over a year, the brand has sold over 2 MILLION cans, making it one of the fastest growing spirits in history.
  • Winona Pure gives consumers movie theatre popcorn in the comfort of their own homes. All the flavor and none of the additives is the story behind these all-natural, non-GMO popcorn seasoning sprays. A simple spray is all it takes to add the perfect pop of flavor to the classic theatre treat.
  • Art of Sport, co-founded by the great Kobe Bryant, is the number one body care brand for athletes. With a growing line of personal care products tested by the world’s greatest athletes, these daily skin essentials give consumers everything they need to feel fresh, stay protected and confident and perform at their peak every day.
  • Skylar is the first and only line of perfumes on the market that are hypoallergenic and safe for sensitive skin. With the strong support of industry titan Sephora, the brand has quickly attracted a loyal following.
  • Soylent is a technological feat. Originally funded by Google Ventures and Andreessen Horwitz, Soylent is dubbed as the world’s most perfect food. Made from sustainably grown plant-based ingredients, Soylent’s line of products is scientifically developed to provide all the functional ingredients, vitamins, minerals, fats, carbohydrates and protein that the body needs – all in convenient, delicious and affordable packages. Soylent’s innovative product line-up includes complete nutrition powders, ready-to-drink shakes, 100-calorie snack bars, high protein nutrition shakes and energy boosting nutrition shakes. Soylent was also the recipient of the 2023 Product of the Year Award by Kantar, a global leader in consumer research.

With award-winning marketing talent, Starco Brands develops robust, integrated marketing plans for every brand in its portfolio, ensuring an impactful presence across all verticals.

Market Outlook

Starco Brands’ varied brand portfolio gives it access to the growth of numerous product categories that are ripe for innovation.

Through its February 2023 acquisition of complete nutrition pioneer Soylent, Starco Brands is positioned to capitalize on the projected growth of the plant-based nutrition space. Research firm Statista valued the plant-based nutrition market at $29.4 billion in 2020 and forecasts its value at nearly $162 billion by 2030, representing a CAGR of 18.7% for the period.

Likewise, Starco Brands gained improved access to the global fragrance market through its December 2022 acquisition of Skylar. According to a report by Grand View Research, the global perfume market was valued at $50.85 billion in 2022 and is expected to grow to a value of nearly $80 billion by 2030, achieving a CAGR of 5.9% over the forecast period.

The company is primed to expand its access to other growth verticals as it advances on its path to invent and acquire behavior-changing technologies and brands.

Management Team

Ross Sklar is the CEO of Starco Brands. A chemical formulator by trade, he started his first company while still in college. Since 2004, he has made over a dozen acquisitions with multiple exits and controls an eclectic collection of industrial, household, personal care and food and beverage manufacturers covering many consumer-packaged goods categories.

Darin Brown is the Chief Operating Officer of Starco Brands. With over 20 years of experience in chemical manufacturing, business development, finance and mergers and acquisitions, he has scaled the company from the ground up. He oversees all internal operations for Starco Brands and is an integral liaison between the company and Mr. Sklar’s manufacturing facilities.

David Dreyer is Chief Marketing Officer of Starco Brands. With over 25 years of experience working with blue chip and startup brands, he oversees all marketing initiatives for the company. Mr. Dreyer comes to Starco having worked with such standout brands as Apple, Pepsi, Pizza Hut, Dr Pepper, Snapple, Infiniti, The GRAMMY’s, Honda and He is also a Professor of Advertising at USC’s Annenberg School for Communication.

Starco Brands Inc. (STCB), closed Wednesday's trading session at $0.18, up 1.6949%, on 44,901 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.115 /$0.265 .

Recent News


The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, continues to make progress in its assessments quantifying the proven and potential gold resources on the Yukon Gold property. Currently GEMXX is working closely with the project's current owners to implement a work plan calling for a pilot mine as soon as weather permits in 2024. With that in mind, the company announced that the closing deadline in the original letter of intent ("LOI") has been extended. The company believes that the project represents a valuable asset and a return on investment ("ROI") with proven resources of 2.2 million ounces of gold. According to the announcement, taking current and forecasted market value of gold into consideration, the project positions the company with an estimated $1 million in revenue, reflecting a robust future revenue stream.

In addition, the project may be a source for rare earth elements and other minerals. GEMXX is evaluating data provided by the current owner to determine the potential for commercial viability for other minerals found on the property. "We are happy to take this project to the next level by detailing the work plan," said GEMXX CEO Jay Maull in the press release. "This one-year initiative will further prove the commercial viability of the property and will lay the groundwork for full-scale 2025 operations. As we approach 2024, various financial analysts and organizations have offered diverse predictions regarding gold prices. The World Gold Council suggests that gold may experience new all-time highs in 2024, aligning with analysts' projections of gold prices reaching or exceeding $2,500 per ounce. This bullish trend is further supported by expectations of the Federal Reserve cutting rates, potentially leading to gold prices hitting fresh highs."

To view the full press release, visit

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.


GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Wednesday's trading session at $0.032, up 6.6667%, on 213,671 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.023 /$0.998 .

Recent News

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

The QualityStocks Daily Newsletter would like to spotlight Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI).

A recent paper that was published in the  "Nature" journal has redefined rheumatoid arthritis (RA) and potentially opened the door to the development of targeted therapies. Researchers analyzed tissue collected from the synovial joints of almost 80 people diagnosed with moderate to high rheumatoid arthritis and built up a massive atlas of RA synovial changes from more than 314,000 single cells. This atlas could potentially lead to the development of targeted therapies that take into account the diversity of the rheumatoid arthritis disease process. Rheumatoid arthritis is an autoimmune disease that typically affects joints in the wrists, hands and knees. The condition inflames the joint lining and damages joint tissue, which can result in symptoms such as chronic or long-lasting pain, deformity, unsteadiness, stiffness, tenderness, swelling in the joint, fever, weight loss and fatigue. The field of autoimmunity is seeing plenty of scientific interest, and enterprises that are investing in developing immunotherapies for autoimmune diseases such as Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) could give patients a respite once the pipelines yield successful results.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, Scinai is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. Scinai is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, Scinai has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, Scinai signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. Scinai anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of Scinai’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

Scinai has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, Scinai will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. Scinai anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

CDMO Services

While NanoAb pipeline development is Scinai’s core focus, the company also offers its cGMP manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for contract development and manufacturing organization (CDMO) services. This offering is designed to keep the Scinai team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb pipeline development.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future Scinai drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is Scinai’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at Scinai. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at Scinai. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining Scinai, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at Scinai. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to Scinai through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), closed Wednesday's trading session at $0.7, up 0%, on 14,536 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.501 /$3.60 .

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, has reached an EV commercial milestone: its Mullen One, a class 1 EV cargo van, received certification from the California Air Resources Board ("CARB") as a zero-emission vehicle in the state of California. This certification means that Mullen ONE can be sold in CARB-compliant states, including California, Connecticut, Colorado, Delaware, Maine, Maryland, Massachusetts, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, Vermont and the District of Columbia. Combined with an earlier certification of conformity received last month from the Environmental Protection Agency ("EPA"), the Mullen ONE is in full compliance with U.S. Federal Motor Vehicle Safety Standards and can be sold in every state. "The CARB certification is an important milestone for Mullen as sales in the CARB-compliant states represents over two-thirds of all EVs sold in the U.S.," said Mullen Automotive CEO and chair David Michery in the press release. "As a next step, we are working to ensure the Mullen ONE is also part of all eligible state incentive programs to further support the sale and adoption of the Mullen ONE across the U.S."

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $0.08, up -11.6998%, on 110,709,628 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $7.72 /$10743.75 .

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

FingerMotion (NASDAQ: FNGR), a mobile services and data company, today provided an update on its big data subsidiary branded Sapientus. Among the highlights, the company reported on the positive positioning of big data models and Sapientus' expectations to engage more partners for commercial applications and expanded use cases. With proprietary analytic models collaboratively tested and validated with empirical insurance data, the past year has been transformative to Sapientus. Studies have demonstrated a high degree of accuracy in their predictive value in tracking substandard cases, which is pivotal in the enhancement of the overall insurance underwriting experience. Extending beyond insurance, the models' analytical capabilities should assist in identifying ideal customers with higher engagement levels. "We are just scratching the surface of what is possible in our big data division," said Martin Shen, CEO of FingerMotion. "Reinsurance is a very large business, but as artificial intelligence has shown us, the market for predictable algorithms is almost infinite."

To view the full press release, visit

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Wednesday's trading session at $3.77, up -5.5138%, on 462,222 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $1.01 /$7.97 .

Recent News

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer's disease and Aging-Related Frailty, is releasing new clinical and biomarker results from the CLEAR MIND trial of its investigational product Lomecel-B(TM). The phase 2a trial evaluates Lomecel-B for the treatment of mild Alzheimer's disease. According to the report, the new data indicates that that Lomecel-B improved cognitive function in multiple measures in a dose-response fashion. In addition, caregiver ratings showed improved quality of life in patients receiving Lomecel-B, and MRI Biomarker study data indicates that Lomecel-B countered loss of brain volume in multiple areas associated with Alzheimer's disease while also reducing brain neuroinflammation and improving cerebral blood flow. The CLEAR MIND trial is a randomized, double-blinded, placebo-controlled study comprised of 50 patients, ages 60 to 85 years of age and diagnosed with mild Alzheimer's disease. "These new data support our initial results for CLEAR MIND that we announced in October and provide further validation of both the safety and therapeutic potential of Lomecel-B in the treatment of mild Alzheimer's disease," said Longeveron CEO Wa'el Hashad in the press release. "We believe these new data may provide evidence for Lomecel-B's mechanism of action and add to the robust foundation we are building for its further investigation in Alzheimer's disease as well as other indications. We anticipate presenting the CLEAR MIND results in a major medical meeting in 2024."

To view the full press release, visit

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.


Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Wednesday's trading session at $1.62, up -16.9231%, on 5,100,159 volume with 00 trades. The average volume for the last 3 months is 357,646 and the stock's 52-week low/high is $1.40 /$4.5793 .

Recent News

Vision Marine Technologies Inc. (NASDAQ: VMAR)

The QualityStocks Daily Newsletter would like to spotlight Vision Marine Technologies Inc. (NASDAQ: VMAR).

More than a trillion dollars is being invested in clean-energy technologies worldwide

Vision Marine Technology's proprietary powertrains will be the inaugural electric motors installed on the Four Winns H2e Bowrider

Order for E-Motion(TM) 180E outboard and powertrain systems marks beginning of transformative partnership with Wired Pontoons

The worldwide clean-energy movement is happening at an amazing rate, according to a recent NPR interview, with an estimated $1.7 trillion being invested in related technologies ( Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, is pioneering the clean-energy transition on the water, selling 100% electric boats, outboard motors and technology to the marine industry.

Vision Marine Technologies Inc. (NASDAQ: VMAR) is a global leader and innovator within the performance electric recreational boating industry. The company is engaged in designing and manufacturing electric outboard powertrain systems and related technology. It strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power, in turn directly contributing to zero pollution, zero emission and a noiseless environment.

Vision Marine manufactures hand-crafted, highly durable, low maintenance, environmentally friendly electric recreational powerboats. The company’s business segments include the sale and rental of electric boats, with the majority of its revenue attributable to electric boat sales.

The designs and technology applied to Vision Marine’s boats result in enhanced performance, higher speeds and longer range. Put simply, Vision Marine boats offer a smoother ride than a traditional internal combustion engine motorboat.

The company is headquartered in Montreal.


Vision Marine’s flagship E-Motion™ 180E electric marine powertrain is the first fully electric outboard powertrain combining advanced battery pack, inverter and high efficiency motor with proprietary union assembly between the transmission and motor. Vision Marine’s E-Motion and related technologies in this system utilize extensive control software and are uniquely designed to improve the efficiency of the outboard powertrain. As a result, both range and performance are enhanced.

More than a powerful electric outboard motor, the 180E is a complete powertrain package. The high-tech, marine-specific motor is equipped with multi-sensor captors and independent cooling, providing 180 horsepower.

An onboard charging system allows for quick and easy charging from any shore outlet, whether the vessel is in or out of the water. It implements cutting-edge marine battery packs that are IP67 certified and built to withstand the harshest marine environments. The system is glycol cooled with a controlled heat exchanger, ensuring optimal performance and longevity. A stainless-steel casing protects the battery from corrosion and physical damage over time.

The 180E is built to be integrated with many boat models produced by other marine manufacturers. Since boat manufacturers rarely build their own engines, instead choosing to source them from engine manufacturers, Vision Marine believes the 180E propulsion system can in the future end up powering nearly every recreational boat.

Market Opportunity

According to a report from Future Market Insights, a certified market research organization, the global electric boats market is expected to grow from a value of $5.6 billion in 2023 to $15.1 billion by 2033, achieving a CAGR of 10.4% during the forecast period.

Factors driving growth include rising seaborne commerce activities, a flourishing marine tourism industry and stringent emissions regulations aimed at reducing pollution. In addition, government support for electric speedboat adoption, advances in technological development and research and forecast expansion of needed charging infrastructure are credited as growth drivers.

An emphasis on reducing carbon emissions and encouraging consumer adoption of eco-friendly boats is also likely to drive expansion of the market, the report states.

Management Team

Alexandre Mongeon is Co-Founder and CEO of Vision Marine Technologies. He has served as CEO since 2014. Prior to that, he imported high-performance boats from the United States to Canada for more than 15 years. During much of that time, he also worked as a designer and contractor and managed several new construction projects on the waterfront in and around Montreal. He is a graduate of the School of Construction in Laval, Quebec, with a specialization in electrical systems.

Xavier Montagne is Chief Technical Officer at Vision Marine. Prior to joining the company, he was the CEO of Mac Engineering for six years. While there, he was the electric powerline architect of the Renault Trezor concept car (awarded 2016 Best Concept Car), technical designer of the Zoe E-sport race car driven in Formula-E races from 2016-2019 and senior battery designer for Forsee Power, SAFT, Renault and Peugeot in Europe, to mention a few of the many projects he headed. He received an electronic engineer diploma from IFITEP Paris Polytech in France.

Kulwant Sandher is CFO at Vision Marine. He is a Chartered Professional Accountant with more than 25 years of experience in business and finance. He has served as CFO of multiple public and private companies, including ElectraMeccanica Vehicles Corp., MineSense Technologies Inc., Alba Mineral Ltd., Delta Oil & Gas, Astorius Resources Ltd., Norsemont Mining Inc. and Intigold Mines Ltd. He graduated from Queen Mary College, University of London.

Vision Marine Technologies Inc. (NASDAQ: VMAR), closed Wednesday's trading session at $1.155, up -1.2821%, on 136,771 volume with 00 trades. The average volume for the last 3 months is 72,531 and the stock's 52-week low/high is $1.01 /$5.60 .

Recent News

Mountain Top Properties Inc. (OTC: MTPP)

The QualityStocks Daily Newsletter would like to spotlight Mountain Top Properties Inc. (OTC: MTPP).

Mountain Top Properties (OTC: MTPP), a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN's sustained effort to provide specialized content distribution via widespread syndication channels. Beau Kelley, CEO of MTPP, and Joseph Kelley, CEO of full service real estate management company On Site Builder Construction Co. Inc., joined the program to discuss the companies and provide insight into the real estate market of the Hamptons. "The real estate market here is already a very well-known, high-end market… and there are not enough of these high-end homes available on the market to satisfy demand," Beau Kelley said. "So, although there are some opportunities to be able to redevelop existing projects, there are fantastic opportunities in ground-up homes. What we do is identify the lot and the area that we want to be in – waterfront and water view are really the premium areas to be. We're really looking forward to being able to get going with two or three projects in the new year, because we see that being just a fantastic way to build shareholder value and partner value over time."

To view the full press release, visit

Mountain Top Properties Inc. (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York.


The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities.

Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets.

The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales.

Mountain Top Capital Fund I LLC

Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise.

This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.

The fund has partnered with On Site Builder Construction Co. Inc., which is managed by Joseph Kelley, who, for over 40 years, has continued to build the highest quality architecturally designed custom houses, varying in style from classic to ultra-modern, in the Hamptons. Several houses he has built are showcased in books and magazines and featured across various forms of digital and social media. His assembled team of skilled subcontractors are among the finest skilled craftsmen in their various fields of expertise.

Mr. Kelley has built over 60 custom homes in this market and has the unique distinction of building the most expensive house sold in Sag Harbor in 2014, which sold for $31,750,000; the most expensive house in the Hamptons in 2019, which first sold for $27,500,000 in 2017 and later was renovated and re-traded for $39,250,000; and the most expensive house sold in the Hamptons in 2022, which sold with the neighboring house for $118,500,000. Mr. Kelley’s portfolio of projects is valued at over $400,000,000. Although he has historically worked as a custom home builder, he would like to shift from providing a service to now providing a finished product in this market.

Market Opportunity

Mountain Top Capital Fund I has a target to raise $75 million to acquire, renovate and remarket Hamptons waterfront or water view properties. The fund has secured debt capital commitments for 70% of the acquisition costs and 100% of the construction costs and will use $10 million to leverage strategic waterfront opportunities in and around the Hamptons.

Profits from each project will be distributed upon the sale of the project, which is anticipated every 15 to 18 months, with a target of a minimum return on investment of 20% to 30% per transaction.

The company anticipates the fund’s Hamptons projects will be followed up by several other funds targeting additional high-end markets.

Management Team

Beau Kelley is CEO, President, CFO and Director of Mountain Top Properties.

Mountain Top Properties Inc. (OTC: MTPP), closed Wednesday's trading session at $0.08, up -20%, on 35,500 volume with 00 trades. The average volume for the last 3 months is 21,446 and the stock's 52-week low/high is $0.0064 /$0.1898 .

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.